271 related articles for article (PubMed ID: 11527144)
1. Bisoprolol and nifedipine SR in the treatment of hypertension in the elderly.
Oliván Martinez J; Garcia MJ; Rodriguez Botaro A; Pizarro JL; Carretero J; Garrido M
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S95-9. PubMed ID: 11527144
[TBL] [Abstract][Full Text] [Related]
2. Effect of bisoprolol and acebutolol on resting blood pressure and on exercise blood pressure profile in hypertensive patients: a comparative, single-blind study.
Bouvier JM; Rabot D; Herrero G
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S179-83. PubMed ID: 11527124
[TBL] [Abstract][Full Text] [Related]
3. Age dependence of therapy result and risk in the treatment of arterial hypertension?
Höffler D; Morgenstern HO
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S184-8. PubMed ID: 11527125
[TBL] [Abstract][Full Text] [Related]
4. Bisoprolol vs. chlorthalidone: a randomized, double-blind, comparative study in arterial hypertension.
Bueno J; Amiguet JA; Carasusan J; Cebollada J; Carretero J
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S189-92. PubMed ID: 11527126
[TBL] [Abstract][Full Text] [Related]
5. Prazosin GITS vs sustained release nifedipine in patients with hypertension and abnormal lipid profile: a randomized, controlled, multicenter study. Madras Hypertension Study Group.
Misra KP; Joglekar SJ; Mukherjee S; Nanivadekar AS
J Assoc Physicians India; 1998; Suppl 1():30-40. PubMed ID: 11233385
[TBL] [Abstract][Full Text] [Related]
6. Hemodynamics and exercise tolerance after bisoprolol, nifedipine, and their combination in patients with angina pectoris.
Schnellbacher K; Bestehorn HP; Roskamm H
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S201-7. PubMed ID: 11527130
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial.
Sramek JJ; Leibowitz MT; Weinstein SP; Rowe ED; Mendel CM; Levy B; McMahon FG; Mullican WS; Toth PD; Cutler NR
J Hum Hypertens; 2002 Jan; 16(1):13-9. PubMed ID: 11840225
[TBL] [Abstract][Full Text] [Related]
8. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine.
Kes S; Caglar N; Canberk A; Deger N; Demirtas M; Dortlemez H; Kiliccioglu B; Kozan O; Ovunc K; Turkoglu C
Curr Med Res Opin; 2003; 19(3):226-37. PubMed ID: 12803737
[TBL] [Abstract][Full Text] [Related]
9. [Effectiveness and tolerability of bisoprolol vs. nifedipine in uremic patients with ischemic cardiopathy in dialysis treatment].
Cice G; Di Benedetto A; Tagliamonte E; Ferrara L; Sorice P; Iacono A
Cardiologia; 1997 Apr; 42(4):397-403. PubMed ID: 9244644
[TBL] [Abstract][Full Text] [Related]
10. Beta-blockers vs. angiotensin-converting enzyme inhibitors in hypertension: effects on left ventricular hypertrophy.
Gosse P; Roudaut R; Herrero G; Dallocchio M
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S145-50. PubMed ID: 11527119
[TBL] [Abstract][Full Text] [Related]
11. Bisoprolol in the treatment of chronic stable angina pectoris.
Terol I; Plaza L; Rodrigo F
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S208-12. PubMed ID: 11527131
[TBL] [Abstract][Full Text] [Related]
12. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.
Philipp T; Smith TR; Glazer R; Wernsing M; Yen J; Jin J; Schneider H; Pospiech R
Clin Ther; 2007 Apr; 29(4):563-80. PubMed ID: 17617280
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the efficacy and safety of trandolapril and nifedipine SR in mild-to-moderate hypertension. Investigator Study Group.
Steiner G; Pauly NC
J Cardiovasc Pharmacol; 1994; 23 Suppl 4():S81-5. PubMed ID: 7527108
[TBL] [Abstract][Full Text] [Related]
14. Antihypertensive efficacy of a slow release nifedipine tablet formulation given once daily in patients with mild to moderate hypertension. A placebo-controlled, double-blind parallel-group trial.
Harder S; Rietbrock S; Thürmann P
Arzneimittelforschung; 1994 Feb; 44(2):133-6. PubMed ID: 8147945
[TBL] [Abstract][Full Text] [Related]
15. A double-blind comparison of bisoprolol and atenolol in patients with essential hypertension.
Wheeldon NM; MacDonald TM; Prasad N; Maclean D; Peebles L; McDevitt DG
QJM; 1995 Aug; 88(8):565-70. PubMed ID: 7648243
[TBL] [Abstract][Full Text] [Related]
16. Nilvadipine in hypertension--experience in ambulatory treatment.
Hoffmann A; Kraul H; Burkardt I
Int J Clin Pharmacol Ther; 1997 May; 35(5):195-203. PubMed ID: 9174874
[TBL] [Abstract][Full Text] [Related]
17. Clinic blood pressure responses to two amlodipine salt formulations, adipate and besylate, in adult Korean patients with mild to moderate hypertension: a multicenter, randomized, double-blind, parallel-group, 8-week comparison.
Lee HY; Kang HJ; Koo BK; Oh BH; Heung-Sun K; Kim KS; Seo HS; Ro YM; Kang JH; Woong CJ; Joo SJ; Kim MH; Joon-Han S; Yoon J; Park SH; Jin-Ok J; Ju AK; Chong-Yun R; Yeon KJ; Park KM; Lim DK; Park SY;
Clin Ther; 2005 Jun; 27(6):728-39. PubMed ID: 16117979
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of delapril plus manidipine compared with enalapril plus hydrochlorothiazide in mild to moderate essential hypertension: results of a randomized trial.
Mugellini A; Dobovisek J; Planinc D; Cremonesi G; Fogari R
Clin Ther; 2004 Sep; 26(9):1419-26. PubMed ID: 15531004
[TBL] [Abstract][Full Text] [Related]
19. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
[TBL] [Abstract][Full Text] [Related]
20. A comparison of felodipine and nifedipine as monotherapies for the treatment of mild to moderate hypertension.
Abelardo NS; Ramos EF; Mendoza VL; Sulit YQ; Mitchell MJ
J Hum Hypertens; 1989 Feb; 3(1):57-9. PubMed ID: 2657058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
